New Acyclic Quinoxaline Nucleosides. Synthesis and Anti-Hiv Activity

REFERENCES

• Chu , C.K. and Cutler , S.J. 1986 . Chemistry and antiviral activities of acyclonucleosides . J. Heterocycl. Chem. , 23 : 289 – 319 .
   Web of Science ®Google Scholar
• Remy , R.J. and Secrist , J.A. III . 1985 . Acyclic nucleosides other than acyclovir as potential antiviral agents . Nucleosides Nucleotides , 4 : 411 – 427 .
   Web of Science ®Google Scholar
• Miyasaka , T. , Tanaka , H. , Baba , M. , Hayakawa , H. , Walker , R.T. , Balzarini , J. and De Clercq , E. 1989 . A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine . J. Med. Chem. , 32 : 2507 – 2509 .
   PubMed Web of Science ®Google Scholar
• Tanaka , H. , Miyasaka , T. , Sekiya , K. , Takashima , H. , Ubasawa , M. , Nitta , I. , Baba , M. , Walker , R.T. and DeClercq , E. 1992 . Synthesis of some analogues of 1-[(2-hydroxyethoxy) methyl]-6-(phenylthio)thymine (HEPT) which have different types of acyclo structure . Nucleotides , 11 : 447 – 456 .
   Web of Science ®Google Scholar
• Elion , G.B. , Furman , J.A. , Fyfe , J.A. , deMiranda , P. , Beauchamp , L. and Schaeffer , H. 1977 . Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine . J. Proc. Natl. Acad. Sci. USA , 74 : 5716 – 5720 .
   PubMed Web of Science ®Google Scholar
• Schaefer , H.J. , Beauchamp , L. , deMiranda , P. , Elion , G.B. , Bauer , D.J. and Collins , P. 1978 . 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group . Nature (London) , 272 : 583 – 585 .
   PubMed Web of Science ®Google Scholar
• Fiddian , A.P. , Brigden , D. , Yeo , J.M. and Hickmott Acyclovir , E.A. 1984 . An update of the clinical applications of this antiherpes agent . Antiviral Res. , 4 : 99 – 177 .
   PubMed Web of Science ®Google Scholar
• Dollins , R. 1985 . Antiviral chemotherapy and chemoprophylaxis . Science , 227 : 1296 – 1303 .
   PubMed Web of Science ®Google Scholar
• Collins , P. and Oliver , N.M. 1985 . Comparison of the in vitro and in vivo antiherpes virus activities of the acyclic nucleosides, acyclovir (Zovirax) and 9-[(2-hydroxy-1-hydroxymethylethoxy)methyl]guanine (BWB759U) . Antiviral Res. , 5 : 145 – 156 .
   PubMed Web of Science ®Google Scholar
• Lavelle , C.L.B. 1993 . Acyclovirl is it effective virostatic agent for oral infections? . J. Oral Path. Med. , 22 : 391 – 401 .
   PubMed Web of Science ®Google Scholar
• Holy , A. 1987 . Phosphonylmethyl analogs of nucleotides and their derivatives: Chemistry and biology . Nucleosides Nucleotides , 6 : 147 – 155 . references cited therein.
   Web of Science ®Google Scholar
• Keller , P.M. , Fyfe , J.A. , Beauchamp , L. , Lubbers , C.M. , Furman , P.A. , Schaeffer , H.J. and Elion , G.B. 1981 . Enzymetic phosphorylation of acyclic nucleoside analogs and correlations ith antiherpetic activities . Biochem. Pharmacol. , 30 : 3071 – 3077 .
   PubMed Web of Science ®Google Scholar
• Larsson , A. , Alenius , S. , Johansson , N.-G. and Oberg , B. 1983 . Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine . Antiviral Res. , 3 : 77 – 86 .
   PubMed Web of Science ®Google Scholar
• Barrio , J.R. , Bryant , J.D. and Keyser , G.E. 1980 . A direct method for the preparation of 2-hydroxyethoxymethyl derivatives of guanine, adenine, and cytosine . J. Med. Chem. , 23 : 572 – 574 .
   PubMed Web of Science ®Google Scholar
• El-Ashry , E.S.H. , El , Kilany and Acyclonulceolsides , Y. 1996 . part 1 seco-Nucleosides . Adv. Heterocycl. Chem. , 67 : 391 – 438 .
   Web of Science ®Google Scholar
• El-Ashry , E.S.H. , El , Kilany and Acyclonulceolsides , Y. 1997 . part 2 diseco-Nucleosides . Adv. Heterocycl. Chem. , 68 : 1 – 88 .
   Web of Science ®Google Scholar
• El-Ashry , E.S.H. , El , Kilany and Acyclonulceolsides , Y. 1998 . part 3., triseco.-Nucleosides . Adv. Heterocycl. Chem. , 69 : 129 – 215 .
   Google Scholar
• Kim , K.S. , Bird , L.Q. , Kickinson , K.E. , Moreland , S. , Schaeffer , T.R. , Waldron , T. , Delany , C.L. , Weller , H.N. and Miller , A.V. 1993 . Quinoxaline. N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships . J. Med. Chem. , 36 : 2335 – 2342 .
   PubMed Web of Science ®Google Scholar
• Bandy , R.B. , Greenblatt , L.P. , Jirkovsky , I.L. , Conklin , M. , Russo , R.J. , Bramlett , D.R. , Emrey , T.A. , Simmonds , J.T. , Kowal , D.M. , Stein , R.P. and Tasse , R.P. 1993 . Potent quinoxaline-spaced phosphono. α-amino acids of the AP-6 type as competitive NMDA antagonists: synthesis and biological evaluation . J. Med. Chem. , 36 : 331 – 342 .
   PubMed Web of Science ®Google Scholar
• Ismail , M.M. , Ammar , Y.A. , Ibrahim , M.K. , El-Zahaby , H.S. and Mahmoud , S. 2005 . Synthesis and pharmacological evaluation of novel quinoxalines as potential nonulcerogenic anti-inflammatory and analgesic agents . Arzneim.-Forsch. , 55 : 738 – 743 .
   PubMed Web of Science ®Google Scholar
• Sarges , R. , Howard , H.R. , Browne , R.G. , Lebel , L.A. , Seymour , P.A. and Koe , B.K. 1990 . 4-Amino[1,2,4]triazolo[4,3-a ]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants . J. Med. Chem. , 33 : 2240 – 2254 .
   PubMed Web of Science ®Google Scholar
• Hazeldine , S.T. , Polin , L , Kushner , J , Paluch , J , White , K , Edelstein , M , Palomino , E. , Corbett , T.H. and Horwitz , J.P. 2001 . Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469) . J. Med. Chem. , 44 : 1758 – 1776 .
   PubMed Web of Science ®Google Scholar
• Fisherman , J.S. , Osborn , B.L. , Chun , H.G. , Plowman , J. , Smith , A.C. , Christian , M.C. , Zaharko , D.S. and Shoemaker , R.H. 1993 . Chloroquinoxaline sulfonamide: a sulfanilamide antitumor agent entering clinical trials . Invest. New Drugs , 11 : 1 – 9 .
   PubMed Web of Science ®Google Scholar
• El Ashry , E.S.H. , Abdel-Rahman , A.A.H. , Rashed , N. and Rasheed , H.A. 1993 . Homoacyclovir analogues of unnatural bases and their activity against Hepatitis B virus . Pharmazie , 54 : 893 – 997 .
   Google Scholar
• Ali , I.A.I. and Fathalla , W. 2006 . N′-Allyl-2-substituted-6,7-dimethyl-1,2-dihydro-2-quinoxalinone as key intermediate for new acyclonucleosides and their regiosomer O-analogues . Heteroatom Chem. , 17 : 280 – 288 .
   Web of Science ®Google Scholar
• Ali , I.A.I. , Al-Masoudi , I.A. , Hassan , H.Gh. and Al-Masoudi , N.A. 2007 . Synthesis and anti-HIV activity of new homo acyclic nucleosides, 1-(pent-4-enyl)quinoxaline-2-ones and 2-(pent-4-enyloxy)quinaloxines . Chem. Heterocycl. Comp. , 482 : 1242 – 1250 .
   Google Scholar
• Al-Masoudi , N.A. , Al-Soud , Y.A. , Eherman , M. and De Clercq , E. 2000 . Synthesis of acyclic nucleoside analogues of 6,7-dihaloquinolones as potential antibacterial and antiviral agents . Bioog. Med. Chem. , 8 : 1407 – 1413 .
   PubMed Web of Science ®Google Scholar
• Al-Masoudi , N.A. , Al-Soud , Y.A. and Geyer , A. 1999 . Synthesis and spectroscopic analysis of some acyclic C-nucleosides and the homo-C-analogues from 1-(chloroalkyl)-1-aza-2-azoniaallene salts . Tetrahedron , 15 : 751 – 758 .
   Web of Science ®Google Scholar
• Al-Masoudi , N.A. and Al-Soud , Y.A. 2004 . N- and C-acyclothiocnucleosides of 1,2,3-triazoles . Heteroatom Chem. , 15 : 380 – 387 .
   Web of Science ®Google Scholar
• Nicols , C.J. and Taylor , M.R. 2005 . The sharpless asymmetric dihydroxylation in the organic chemistry majors laboratory . J. Chem. Ed. , 82 : 105 – 108 .
   Web of Science ®Google Scholar
• Bax , A. , Griffey , R.H. and Hawkins , B.L. 1983 . Correlation of proton and nitrogen-15 chemical shifts by multiple quantum NMR . J. Magn. Reson. , 55 : 301 – 315 .
   Web of Science ®Google Scholar
• Al-Masoudi , N.A. , Al-Soud , Y.A. and Geyer , A. 1998 . 1H- and 13C-NMR study of some 6,7-dihaloquinolone nucleosides and their derivatives . Spectroscopy Lett , 31 : 1031 – 1038 .
   Web of Science ®Google Scholar
• Willker , W. , Leibfritz , D. , Kerssebaum , R. and Bermel , W. Gradient selection in inverse heteronuclear correlation spectroscopy . Mag. Reson. Chem. , 31 287 – 292 .
   Web of Science ®Google Scholar
• El Ashry , E.S.H. , Abdel-Rahman , A.A.-H. , Rashid , N. and Rasheed , H.A. 1999 . Arch. Pharm. Pharm. Med. Chem. , : 327 – 330 .
   PubMed Web of Science ®Google Scholar
• Pauwels , R. , Balzarini , J. , Baba , M. , Snoeck , R. , Schols , D. , Herdewijn , P. , Desmyter , J. and De Clercq , E. 1988 . Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds . J. Virol. Methods , 20 : 309 – 321 .
   PubMed Web of Science ®Google Scholar
• Young , S.D. , Britcher , S.F. , Tran , L.O. , Payne , L.S. , Lumma , W.C. , Lyle , T.A. , Huff , J.R. , Anderson , P.S. , Olsen , D.B. , Carroll , S.S. , Pettibone , D.J. , Obrien , J.A. , Ball , R.G. , Balani , S.K. , Lin , J.H. , Chen , I.W. , Schleif , W.A. , Sardana , V.V. , Long , W.J. , Byrnes , V.W. and Emini , E.A. 1995 . Novel, highly potent non-nucleoside inhibitor of the human immunodeficiency-virus type-1 reverse transcriptase . Antimicrob. Agents Chemother. , 39 : 2602 – 2605 .
   PubMed Web of Science ®Google Scholar
• Fujiwara , T. , Sato , A. , El-Farrash , M. , Miki , S. , Kabe , K. , Isaka , Y. , Kodama , M. , Wu , Y.M. , Chen , L.B. , Harada , H. , Sugimoto , H. , Hatanaka , M. and Hinuma , Y. 1998 . Capravirine (AG-1549): Non-nucleosides RTI . Antimicrob. Agents. Chemother. , 42 : 1340 – 1345 .
   PubMed Web of Science ®Google Scholar